PRESS RELEASE published on 02/04/2025 at 10:35, 2 months ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF published on 10/01/2024 at 00:56, 6 months 3 days ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:56, 6 months 3 days ago Valerio Therapeutics publie ses résultats financiers du premier semestre 2024 Résultats Financiers R&D Essai Clinique Valerio Therapeutics Anticorps À Domaine Unique
PRESS RELEASE published on 10/01/2024 at 00:51, 6 months 3 days ago Inside Information: News release on accounts, results Valerio Therapeutics annonce ses résultats financiers du Premier Semestre 2024 et fait le point sur ses activités, y compris l'acquisition d'Emglev Therapeutics et le développement de la plateforme PlatONTM Résultats Financiers Biotechnologie Valerio Therapeutics Emglev Therapeutics Plateforme PlatONTM
BRIEF published on 10/01/2024 at 00:45, 6 months 3 days ago Valerio Therapeutics publie ses résultats financiers du premier semestre 2024 et ses mises à jour stratégiques Résultats Financiers Plateforme PlatONTM Acquisition D'Emglev Essai Clinique VIO-01 Innovations Thérapeutiques
BRIEF published on 10/01/2024 at 00:45, 6 months 3 days ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 6 months 3 days ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 6 months 3 days ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
PRESS RELEASE published on 09/30/2024 at 22:40, 6 months 3 days ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 08/05/2024 at 19:23, 7 months 29 days ago Half-yearly review of the liquidity contract with Kepler Cheuvreux Liquidity Contract Transactions Kepler Cheuvreux AMF Valerio Therapeutics
Published on 04/04/2025 at 15:10, 33 minutes ago China Launches New Precision Strike Against Pengaton Rare Earth Supply Chains
Published on 04/04/2025 at 00:00, 15 hours 43 minutes ago Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Published on 04/03/2025 at 15:05, 1 day ago Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 1 day ago Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/03/2025 at 15:00, 1 day ago UniDoc Announces Debt Settlement and Renews Marketing Engagement
Published on 04/04/2025 at 14:59, 43 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/04/2025 at 14:58, 44 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 04/04/2025 at 14:58, 44 minutes ago Funding Circle Holdings plc: Publication of 2024 Annual Report and Notice of 2025 Annual General Meeting
Published on 04/04/2025 at 14:57, 45 minutes ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Published on 04/04/2025 at 14:52, 50 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d'actions composant le capital
Published on 04/04/2025 at 10:10, 5 hours 32 minutes ago Mise à disposition du Document d'enregistrement Universel 2024
Published on 04/04/2025 at 00:04, 15 hours 38 minutes ago Carrefour relève son offre sur Carrefour Brésil
Published on 04/04/2025 at 00:04, 15 hours 38 minutes ago Carrefour raises its offer for Carrefour Brazil
Published on 04/03/2025 at 18:46, 20 hours 56 minutes ago Monthly disclosure of the total number of shares and voting rights - March 2025
